Literature DB >> 27719979

Imaging of Acute Lung Injury.

Brett M Elicker1, Kirk T Jones2, David M Naeger3, James A Frank4.   

Abstract

Acute lung injury (ALI) is the clinical syndrome associated with histopathologic diffuse alveolar damage. It is a common cause of acute respiratory symptoms and admission to the intensive care unit. Diagnosis of ALI is typically based on clinical and radiographic criteria; however, because these criteria can be nonspecific, diagnostic uncertainty is common. A multidisciplinary approach that synthesizes clinical, imaging, and pathologic data can ensure an accurate diagnosis. Radiologists must be aware of the radiographic and computed tomographic findings of ALI and its mimics. This article discusses the multidisciplinary diagnosis of ALI from the perspective of the imager.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute eosinophilic pneumonia (AEP); Acute fibrinous organizing pneumonia (AFOP); Acute interstitial pneumonia (AIP); Acute lung injury (ALI); Acute respiratory distress syndrome (ARDS); Diffuse alveolar damage (DAD)

Mesh:

Year:  2016        PMID: 27719979     DOI: 10.1016/j.rcl.2016.05.006

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  10 in total

1.  Anti-inflammatory Role of Pilose Antler Peptide in LPS-Induced Lung Injury.

Authors:  Chunhua Ma; Hongyan Long; Chunhui Yang; Wenjun Cai; Tianzhu Zhang; Wenhai Zhao
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

Review 2.  Imaging the Injured Lung: Mechanisms of Action and Clinical Use.

Authors:  Maurizio Cereda; Yi Xin; Alberto Goffi; Jacob Herrmann; David W Kaczka; Brian P Kavanagh; Gaetano Perchiazzi; Takeshi Yoshida; Rahim R Rizi
Journal:  Anesthesiology       Date:  2019-09       Impact factor: 7.892

3.  ROS Signaling in the Pathogenesis of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS).

Authors:  Manuela Kellner; Satish Noonepalle; Qing Lu; Anup Srivastava; Evgeny Zemskov; Stephen M Black
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 4.  Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology.

Authors:  Javier Checa; Josep M Aran
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

5.  All‑trans retinoic acid promotes macrophage phagocytosis and decreases inflammation via inhibiting CD14/TLR4 in acute lung injury.

Authors:  Shuangxue Li; Yuansheng Lei; Jieyun Lei; Hui Li
Journal:  Mol Med Rep       Date:  2021-10-22       Impact factor: 2.952

6.  Emodin Protects Against Lipopolysaccharide-Induced Acute Lung Injury via the JNK/Nur77/c-Jun Signaling Pathway.

Authors:  Pei Xie; Li-Jun Yan; Hong-Ling Zhou; Hui-Hui Cao; Yuan-Ru Zheng; Zi-Bin Lu; Hua-Yi Yang; Jia-Mei Ma; Yu-Yao Chen; Chuying Huo; Chunyang Tian; Jun-Shan Liu; Lin-Zhong Yu
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.810

7.  Aspirin eugenol ester alleviates lipopolysaccharide-induced acute lung injury in rats while stabilizing serum metabolites levels.

Authors:  Qi Tao; Zhen-Dong Zhang; Zhe Qin; Xi-Wang Liu; Shi-Hong Li; Li-Xia Bai; Wen-Bo Ge; Jian-Yong Li; Ya-Jun Yang
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

8.  Down-regulation of long non-coding RNA SNHG14 protects against acute lung injury induced by lipopolysaccharide through microRNA-34c-3p-dependent inhibition of WISP1.

Authors:  Jinyuan Zhu; Jijia Bai; Shaojin Wang; Hui Dong
Journal:  Respir Res       Date:  2019-10-28

9.  Ganoderic Acid A Alleviates OVA-Induced Asthma in Mice.

Authors:  Xinhua Lu; Chenyang Xu; Rui Yang; Guojun Zhang
Journal:  Inflammation       Date:  2021-05-26       Impact factor: 4.092

Review 10.  Critically ill patients with cancer: A clinical perspective.

Authors:  Frank Daniel Martos-Benítez; Caridad de Dios Soler-Morejón; Karla Ximena Lara-Ponce; Versis Orama-Requejo; Dailé Burgos-Aragüez; Hilev Larrondo-Muguercia; Rahim W Lespoir
Journal:  World J Clin Oncol       Date:  2020-10-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.